Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase
Open Access
- 1 August 1990
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 172 (8) , 4348-4351
- https://doi.org/10.1128/jb.172.8.4348-4351.1990
Abstract
The cephalosporinase of Citrobacter freundii GN346 is a class C beta-lactamase, consisting of 361 amino acids and exhibiting the substrate profile of a typical cephalosporinase. On the conversion of a conserved glutamic acid at residue 219 to lysine, the substrate spectrum of the cephalosporinase was extended to oxyimino cephalosporins, aztreonam and carbenicillin, which are essentially undesirable substrates for the enzyme. Escherichia coli cells carrying the mutant gene showed higher resistance levels to cefuroxime, aztreonam, and carbenicillin, but a lower resistance level to cefoxitin, than cells carrying the wild gene. The kcat values of the purified mutant enzyme for ceftazidime, cefuroxime, and cefmenoxime were 77,100, and 300 times those of the wild enzyme, respectively. The relative Vmax values of the mutant enzyme for aztreonam and carbenicillin were determined to be 11 and 23 times those of the wild enzyme, respectively, but the value of the mutant enzyme for cefoxitin was only one-third that of the wild enzyme.This publication has 26 references indexed in Scilit:
- Role of lysine‐67 in the active site of class C β‐lactamase from Citrobacter freundii GN346European Journal of Biochemistry, 1990
- Refined crystal structure of β-lactamase from Citrobacter freundiiindicates a mechanism for β-lactam hydrolysisNature, 1990
- Mechanism of beta-lactamase inhibition: Differences between sulbactam and other inhibitorsDiagnostic Microbiology and Infectious Disease, 1989
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- Amino Acid Sequence, Active-Site Residue, and Effect of Suicide Inhibitors on Cephalosporinase of Citrobacter freundii GN346Clinical Infectious Diseases, 1988
- Identification of the active site of Citrobacter freundii β‐lactamase using dansyl‐penicillinFEBS Letters, 1987
- Bacterial Resistance to β-Lactam Antibiotics: Crystal Structure of β-Lactamase from Staphylococcus aureus PC1 at 2.5 Å ResolutionScience, 1987
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985
- Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactamAntimicrobial Agents and Chemotherapy, 1983
- The structure of β-lactamasesPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980